Since being one of the main cytokines produced by NK cells, IFN-γ levels in NK cells (especially in CD56bright cell subset) of MS patients have been measured in several studies, and shown to be impaired in CD56bright NK cells of untreated RR-MS patients (217). This evidence concerns the gene IFNG and myeloid sarcoma.